Ireland
--:--IST
Latest
Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year
Clinical Trials in France / NCT06677268
Recruiting Not applicable

Respiratory Rehabilitation and Sleep Quality in COPD Patients

NCT06677268 · tracked via the Priya Life Science France tracker
Sponsor
University Hospital, Rouen
Phase
Not applicable
Started
2025-02-19
Last updated
2026-02-18

Condition(s) studied

COPD (Chronic Obstructive Pulmonary Disease)

Investigational drug(s) / intervention(s)

Rehabilitation

Rehabilitation: Patients will undergo a respiratory rehabilitation program (24 exercise sessions of 90 minutes each, three times a week for 8 weeks and up to 9 therapeutic education workshops of 1 hour)

Study summary

COPD affects 5 to 8% of the population in France. The disease consists of inflammation of the large and small airways causing permanent obstruction of the airways and symptoms such as dyspnea, cough and sputum that worsens over time.

Among all COPD patients, 40% complain of sleep disorders. Polysomnography data showed a prolongation of sleep onset latency and a decrease in deep sleep, correlated with the severity of daytime hypoxemia. Conversely, poor sleep quality leads to an increase in dyspnea, altered quality of life and increased occurrence of COPD exacerbations.

Respiratory rehabilitation has demonstrated significant benefits on exercise capacity, dyspnea, COPD exacerbations and quality of life. To the investigators' knowledge, a few studies have investigated the relationship between physical activity and sleep quality using polysomnography in this population. Thus, the aim of the study is to evaluate the benefits of respiratory rehabilitation on sleep architecture in patients with COPD. Investigators' hypothesis is that a respiratory rehabilitation program would improve the quality of sleep measured by polysomnography. Therefore, patient with COPD and no exacerbation in the previous year will be randomly assigned to the interventional group who perform the rehabilitation program or to the control group who will not perform the program. The primary endpoint is the sleep quality estimated by total sleep time as measured by the mean of 2 independent polysomnography readings, at baseline and after the RR program in the interventional group and after 2 months of usual care in the control group.

Eligibility

Sex
ALL
Min age
50 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Male or female ≥ age 50 * COPD defined according to the GOLD 2022 criteria, clinically stable (without exacerbation for at least 4 weeks), with indication for respiratory rehabilitation * Absence of respiratory rehabilitation in the past 12 months * Patient affiliated to the social security system * For women of childbearing potential who have been on effective contraception (estrogen-progestogen or intrauterine device or tubal ligation) for 1 month. * For postmenopausal women: confirmatory diagnosis (non-medically induced amenorrhea for at least 12 months prior to the inclusion visit) * Patient who has read and understood the information letter and signed the consent form Exclusion Criteria: * BMI≥ 30 kg/m2 * Previously documented OSA (AHI \> 10/h) * Patient with a CPAP or NIV * Patient on systemic corticosteroid therapy * Patient on centrally acting therapy (benzodiazepine or opiate) * Patient with an occurrence of severe COPD exacerbation * Patient with other associated chronic respiratory insufficiency * Patient with active cancer * Patient with neuromuscular disease * Patient with an osteoarticular disability or traumatic or neurological sequelae preventing participation in the respiratory rehabilitation program * Psychiatric, cognitive or linguistic disorders with inability to understand to follow the protocol * Patient with a contraindication to respiratory rehabilitation or any pathology preventing physical rehabilitation * Patient with a cardiovascular contraindication to respiratory rehabilitation * Person deprived of liberty by an administrative or judicial decision or person placed under judicial safeguard, guardianship or curatorship * Person subject to a legal protection measure * Pregnant or parturient or breastfeeding woman

Primary outcome measure(s)

  • Total sleep time (TST) — Baseline and end of respiratory rehabilitation (2 months)
    measured by the average of the 2 independent polysomnography scorings

Trial sites (4)

FacilityCityRegionStatus
Chu Amiens Amiens France Not Yet Recruiting
Gh Le Havre Le Havre France Not Yet Recruiting
Centre de Sante Adir Rouen France Not Yet Recruiting
Chu Rouen Rouen France Recruiting

More University Hospital, Rouen trials in France

Comparison of the Effects of Belatacept and Anticalcineurins on Endothelial Function in Renal Transplant Patients - <BELAFENDO> Recruiting
Evaluation of Gynecological and Sexual Sequelae Recruiting
APA (Adapted Physical Activity) for Patients With Advanced Melanoma Recruiting
Aortic Stenosis: Determinants of Progression, Severity and Left Ventricular Remodeling Active, not recruiting
Effect of Preventive Analgesia by Injection of a Local Anesthetic Before Vaginal Incision for Hysterectomy by vNOTES Approach Recruiting

Other trials for the same condition

Creation of a Biological Collection of BRonchiaI and Pulmonary Tissues From Surgical wastE Starting soon
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease Recruiting
Validation of the French Version of the QASCI in Caregivers of Patients With COPD Recruiting
Prevalence and Functional Impact of Urinary Incontinence in Women With Chronic Obstructive Pulmonary Disease Undergoing Rehabilitation: a Cross-sectional Study Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06677268 on ClinicalTrials.gov ↗ ← All trials in France